Patient-reported factors associated with the desire to continue taking sleep-inducing drugs after hospital discharge: A survey of older adults.
Aged
Aged, 80 and over
Cross-Sectional Studies
Decision Making
Female
Germany
/ epidemiology
Health Services for the Aged
Humans
Hypnotics and Sedatives
/ administration & dosage
Male
Patient Discharge
Patient Reported Outcome Measures
Pharmacoepidemiology
Sleep Initiation and Maintenance Disorders
/ drug therapy
Surveys and Questionnaires
aged
drug utilization
hospitals
hypnotics and sedatives
pharmacoepidemiology
sleep initiation and maintenance disorders
surveys and questionnaires
Journal
Pharmacoepidemiology and drug safety
ISSN: 1099-1557
Titre abrégé: Pharmacoepidemiol Drug Saf
Pays: England
ID NLM: 9208369
Informations de publication
Date de publication:
07 2019
07 2019
Historique:
received:
01
02
2019
revised:
26
04
2019
accepted:
27
04
2019
pubmed:
11
6
2019
medline:
19
5
2020
entrez:
11
6
2019
Statut:
ppublish
Résumé
To find out whether any prior experiences with sleep-inducing drugs before hospitalization and positive experiences with these drugs during hospitalization influence a patient's wish to continue taking sleep-inducing drugs after hospitalization. We surveyed older hospital patients about use of sleep-inducing drugs before, during, and after hospitalization and compared these answers with their hospital chart using the kappa statistic. The association between the wish to continue these drugs after discharge and the perceived benefits, experience of side effects, and prior experience with sleep-inducing drugs was determined by multivariable logistic regression. Agreement between patient responses and the hospital file was high (κ = 0.7). Seventeen percent (83/483) of the participants reported prior experience before their hospital stay; 45% received a sleep-inducing drug during hospitalization; 17% wished to continue taking them after discharge. Of the 400 patients who had no prior experience with sleep-inducing drugs, 147 (37%) became first-time users in the hospital, and 27% (40/147) of these wished to continue this medication after discharged. Strong predictors for this wish were the reduction of sleep onset problems (adjusted odds ratio, 6.26; 95% confidence interval, 2.38-16.44) and any prior experience with sleep-inducing drugs (4.08; 1.97-8.48). Many older patients become first-time users of sleep-inducing drugs in the hospital. Especially the experience of sleep onset improvements influences the wish to continue sleep-inducing drug use after discharge. Avoiding first-time use should become a goal of hospital policy and be taken into account when weighing the benefits and risks of sleep-inducing drugs.
Identifiants
pubmed: 31179613
doi: 10.1002/pds.4806
pmc: PMC6618328
doi:
Substances chimiques
Hypnotics and Sedatives
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1014-1022Informations de copyright
© 2019 The Authors Pharmacoepidemiology and Drug Safety Published by John Wiley & Sons Ltd.
Références
Int J Qual Health Care. 2016 Oct;28(5):540-553
pubmed: 27512130
Pharmacoepidemiol Drug Saf. 2013 Jul;22(7):719-27
pubmed: 23585247
Dtsch Arztebl Int. 2015 Jan 5;112(1-2):1-7
pubmed: 25613443
J Clin Med. 2018 Jan 30;7(2):
pubmed: 29385766
BMJ. 2005 Nov 19;331(7526):1169
pubmed: 16284208
Eur J Clin Pharmacol. 2019 Jan;75(1):87-97
pubmed: 30215101
PLoS One. 2016 Jun 09;11(6):e0156735
pubmed: 27280292
J Gen Intern Med. 2007 Jul;22(7):1024-9
pubmed: 17453266
Drugs Aging. 2012 Jul 1;29(7):565-76
pubmed: 22715863
Eur J Clin Pharmacol. 2011 Jul;67(7):723-9
pubmed: 21279338
BMC Pharmacol Toxicol. 2017 Dec 04;18(1):76
pubmed: 29202811
Perm J. 2017 Apr 20;22:17-157
pubmed: 29702055
Pharmacoepidemiol Drug Saf. 2019 Jul;28(7):1014-1022
pubmed: 31179613
Drugs Real World Outcomes. 2017 Dec;4(4):225-234
pubmed: 28936700
Drugs R D. 2017 Dec;17(4):493-507
pubmed: 28865038
Postgrad Med. 2018 Sep;130(7):627-636
pubmed: 30044682
J Clin Nurs. 2009 Nov;18(22):3098-106
pubmed: 19538562
Prescrire Int. 2008 Oct;17(97):206-12
pubmed: 19536941
Acta Med Croatica. 2012 May;66(2):137-40
pubmed: 23437641
Br J Gen Pract. 2008 Jun;58(551):417-22
pubmed: 18505619
Pharmacopsychiatry. 1993 Jan;26(1):11-4
pubmed: 8378406
Age Ageing. 2018 Mar 1;47(2):201-208
pubmed: 29077902
Swiss Med Wkly. 2018 Feb 14;148:w14590
pubmed: 29442341
BMJ Open. 2016 Aug 05;6(8):e011908
pubmed: 27496238
Neuropsychopharmacology. 2006 Apr;31(4):832-44
pubmed: 16237393
JAMA Intern Med. 2018 Sep 1;178(9):1201-1208
pubmed: 30014139